Home/Filings/4/0001062993-22-015169
4//SEC Filing

Campbell Michael Gerard 4

Accession 0001062993-22-015169

CIK 0001907685other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:59 PM ET

Size

5.3 KB

Accession

0001062993-22-015169

Insider Transaction Report

Form 4
Period: 2022-06-15
Campbell Michael Gerard
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Purchase)

    2022-06-15+450,000450,000 total
    Exercise: $3.72Exp: 2032-06-15Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest over four (4) years, with twenty-five percent (25%) of the shares of Common Stock underlying the option vesting on June 15, 2023 and the remainder vesting in equal monthly installments thereafter.

Issuer

Comera Life Sciences Holdings, Inc.

CIK 0001907685

Entity typeother

Related Parties

1
  • filerCIK 0001934174

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:59 PM ET
Size
5.3 KB